Extracorporeal Membrane Oxygenation Machine Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

Extracorporeal Membrane Oxygenation Machine Market Trends and Growth Drivers

Technological Enhancements Are a Major Trend

• The continuous technical advancements in ECMO machines facilitate their improvement to a more-compact system with upgraded maneuverability, safety, and portability.
• The new ECMO devices are more integrated and user-friendly, which boosts their adoption not only in clinical and hospital settings but also in long-term care, nursing, hospice, and homecare environments.
• The advent of polymethyl pentene (PMP) fiber technology is also a remarkable innovation as this membrane offers less resistance, biocompatibility, and long-term usability.
• Enhancements in extracorporeal carbon dioxide removal techniques promise to cure hypercapnia and respiratory deficits.

Growing Awareness of Merits of ECMO Devices Will Drive Market

The adoption of ECMO therapy will increase as the awareness of its benefits for severe respiratory and cardiac diseases rises. The launch of awareness programs for ECMO machines and their applications in developing regions, such as Asia and the Middle East, results in the surging demand for these machines.

In association with the Society for Emergency Medicine India and the Association of Healthcare Providers India, Fortis Hospital Mulund conducted India's first International Federation of Emergency Medicine (IFEM) workshop in August 2024. Dedicated to ECMO for emergency medicine doctors, it equipped specialists and delegates with practical training and critical skills for ECMO initiation, cannulation, and intra-aortic balloon pumping.

Similarly, In LATAM, the Latina Preventive Heart Disease (LPHD) program has been launched with the goal of raising awareness of improved therapies and tools for CVD disorders.

Complications Associated with ECMO Hamper Market Growth

• While innovations in ECMO have reduced the severity and chances of complications, there still exist multiple risks that affect the overall effectiveness of the procedure.
• These issues include coagulopathy, infections, thrombosis, transfusion problems, pump failure, small clots, and an increase in the chances of strokes.
• Anticoagulation, which is essential to avoid thrombosis in the tubing, can induce bleeding disorders, thereby making hemorrhagic events at cannulation sites more likely.
• The mechanical ventilation of ECMO can result in aggravating lung injury, prolonged recovery, and pneumonia associated with ventilators.
• Therefore, the innate complications of this treatment necessitate close monitoring, a multidisciplinary approach, and trained healthcare professionals.

Extracorporeal Membrane Oxygenation Machine Market Analysis

Component Analysis

• The oxygenators category held the largest revenue share, of ~40%, in 2024 in the market, and it is further projected to have the highest CAGR over the forecast period.
• This is due to the rising incidence of severe lung diseases among children and the growing awareness regarding the applications of ECMO devices.
• Moreover, these oxygenators are majorly used by perfusionists in cardiac surgical procedures in conjunction with heart-lung machines and are also extensively used in neonatal intensive care units associated with ECMO machines.
• The heat-cooler unit category is expected to witness significant growth during the forecast period.
• This can be ascribed to the wide use of these units in cardiothoracic or transplantation surgeries and the increase in incidences of cardiopulmonary diseases such as chronic obstructive pulmonary diseases and cystic fibrosis.

The components analyzed here are:

• Pumps
• Oxygenators (Largest and Fastest-Growing Category)
• Heater-Cooler Units
• Tubes
• Others

Patient Type Analysis

• In the ECMO market, the adult category generates the highest revenue, predominantly because of the rising geriatric population and increasing prevalence of critical illnesses in it.
• Life-threatening respiratory and cardiac conditions, such as cardiogenic shock, ARDS, cardiac arrest, and traumatic lung injuries, make adults a common recipient of ECMO therapy.
• Moreover, adults undergo a high number of heart and lung surgeries during which ECMO is needed.
• The neonates category is the fastest growing, with a CAGR of 8.0%, during this decade.
• As per the Centers for Disease Control and Prevention (CDC), nearly 1%—or 40,000 babies—are born with a congenital heart defect (CHD) in the U.S. each year. In total, 1 out of 4 babies suffers from a heart defect.
• The increasing rate of heart disorders, pneumonia, respiratory distress syndrome, CDH, and other serious illnesses among neonates makes ECMO support imperative.
• This has resulted in an expansion of dedicated programs and resources and the creation of special devices for this population.

The patient types analyzed here are:

• Neonates (Fastest-Growing Category)
• Pediatrics
• Adults (Largest Category)

Modality Analysis

Veno-arterial is the largest category in the extracorporeal membrane oxygenation machine market, with ~50% revenue, and it is the fastest-growing category too.

This can be attributed to its effectiveness and reliability in the exchange of gases, widespread use in cardiac arrest patients, and assistance with algorithmic life support techniques to reestablish blood flow.

Additionally, it is widely used to treat patients with thromboembolism and pulmonary hypertension, particularly in cases of abrupt decompensation, which leads to the extracorporeal membrane oxygenation machine market expansion.

The modalities analyzed here are:

• Veno-Arterial (Largest and Fastest-Growing Category)
• Veno-Venous
• Arterio-Venous

Application Analysis

ECMO machines used for respiratory applications accounted for the largest revenue share in 2024.

The rise in prevalence of target diseases increased smoking and tobacco use, and excessive alcohol consumption, which can lead to chronic diseases or respiratory failure, and the high need for early diagnosis and diagnostic imaging are the key factors responsible for the increasing market share of this category.

Extracorporeal cardiopulmonary resuscitation (ECPR) is the fastest-growing category, with a CAGR of 9.34%. This is owing to the increasing acknowledgment of the role of ECPR in treating cardiac arrest. The American Heart Association (AHA) and the Extracorporeal Life Support Organization (ELSO) suggest ECPR as it increases the rate of survival and neurological recovery compared to traditional CPR.

The applications analyzed here are:

• Respiratory (Largest and Fastest-Growing Category)
• Cardiac
• ECPR (Fastest-Growing Category)

Extracorporeal Membrane Oxygenation Machine Market Geographical Outlook

Geographically, the North American market reported the largest revenue share, of around 40%, in 2024, and it is also projected to maintain its position in the coming years. This is ascribed to the presence of a substantial patient base suffering from cardiopulmonary disorders and respiratory failure and the surge in the rate of adoption of ECMO machines in regional hospitals.

In addition, the U.S. contributes the majority of revenue to the regional market. This is due to the presence of a large number of market players, advanced healthcare infrastructure, high healthcare spending, and a high prevalence of CVDs and respiratory disorders in the country.

The APAC extracorporeal membrane oxygenation machine market will register the fastest growth, at a CAGR of over 8.52%, during 2025–2032. This can be attributed to the growing public awareness of ECMO machines and their merits, the rising aging population, and the surging efforts by various governments and business organizations to attract foreign direct investment (FDI) in the medical equipment and healthcare sectors.

Moreover, China is the major revenue generator in the regional market. This is due to its evolving healthcare infrastructure, a high success rate of ECMO machines during cardiothoracic surgeries, and high investment by market giants to set up their facilities in the country.

In addition, Europe held a significant revenue share in the market in 2024, and it is expected to maintain the same trend in the coming years. This is ascribed to the increased adoption of cutting-edge ECMO devices by medical institutions in European nations, coupled with the rising number of patients with respiratory and cardiac disorders in the region.

Furthermore, Germany is the major revenue contributor to the regional market, as it has advanced technologies associated with ECMO machines and high R&D spending in the field of the healthcare sector.

The Geographical breakdown of the market is as follows:

• North America (Largest Regional Market)
  • U.S. (Larger Country Market)
  • Canada (Faster-Growing Country Market)
• Europe
  • Germany (Largest Country Market)
  • Italy (Fastest-Growing Country Market
  • U.K.
  • France
  • Spain
  • Rest of Europe
• Asia-Pacific (APAC) (Fastest-Growing Regional Market)
  • China (Largest Country Market)
  • India (Fastest-Growing Country Market)
  • South Korea
  • Japan
  • Australia
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest Country Market)
  • Mexico (Fastest-Growing Country Market)
  • Rest of LATAM
• Middle East and Africa (MEA)
  • U.A.E. (Largest Country Market)
  • Saudi Arabia (Fastest-Growing Country Market)
  • South Africa
  • Rest of MEA

Extracorporeal Membrane Oxygenation Machine Market Share

The ECMO market is fragmented in nature as the cases of critical illnesses are rising with the surging population and pollution. This leads to a greater number of adults, pediatrics, and neonates suffering from heart and lung diseases. There are also several manufacturers, each catering to different clinical and hospital needs. The healthcare infrastructure, treatment guidelines, and government regulations in each country are also different, which leads to a diversified market landscape. ECMO also has varied applications such as cardiac, respiratory, and ECPR, leading to specialized machines engineered for specific patient populations.

Extracorporeal Membrane Oxygenation Machine Market News

In September 2024, Medtronic plc launched VitalFlow, an integrated ECMO system engineered to offer clinicians a user-friendly experience. This system is reliable, portable, and durable.

In May 2024, MicroPort Scientific Corporation’s acquired company Hemovent announced that it has completed the installation of MOBYBOX, an all-in-one portable pneumatic ECMO system, in Europe. This device is portable and has received the Medical Device Regulation Certification. Apart from Germany, Italy, Greece, the Netherlands, and Israel, the company is making attempts to expand access to it in China, the U.S., and the Middle East.

In April 2023, Abbott Laboratories attained two new approvals from the U.S. Food and Drug Administration (FDA) for its life support systems, particularly the CentriMag Blood Pump. The FDA indication facilitates longer-term life ECMO support to adults suffering from critical illness.